Ticker brief
KURA KURA ONCOLOGY INC
Consumer, Non-cyclical · Biotechnology
last close
$12.66
1 day
-3.9%
14 days
+16.6%
mkt cap
$985.4M
signals 14d
52
authors 14d
22
crowd 14d
+0.8σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 59% | IV/HV 0.82× (as of 2026-02-24) |
| Skew — 25Δ RR 30d | -0.295 | 25Δ call IV − put IV |
| OI alarm | quiet | last alarm 2026-06-23 (z=2.0) |
Sentiment — last 14 days
daily mean sentiment, 2026-08-17 → 2026-08-27 · now +0.55 (−1 bearish … +1 bullish)
Who spoke22
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Brad_E_Schulz | C | · | 7 | +0.29 |
| @Maximus_Holla | C | +0.80 | 6 | +0.51 |
| @semodough | C | -3.01 | 5 | +0.23 |
| @jimmyhuli | C | -0.15 | 4 | +0.50 |
| @LogicalThesis | A | +2.21 | 3 | +0.48 |
| @Briefingcom | B | +0.50 | 3 | +0.20 |
| @OpenOutcrier | C | · | 2 | +0.15 |
| @judahrhodie | C | +1.14 | 2 | +0.30 |
| @CEOStockWatcher | C | · | 2 | +0.30 |
| @OptionsFlowBoss | C | · | 2 | +0.45 |
| @MinervaCap | C | -0.39 | 2 | +0.05 |
| @zohmbastic | C | -1.38 | 2 | +0.30 |
| @eugeniodeveze | C | +1.08 | 2 | +0.30 |
| @sunxliao | B | -2.09 | 2 | +0.57 |
| @ClassicRoy | C | -1.52 | 1 | +0.00 |
| @BeatTheInsider | C | · | 1 | +0.30 |
| @kunal00 | C | -0.85 | 1 | +0.00 |
| @Quantumup1 | C | · | 1 | +0.25 |
| @TENETTRADEGROUP | C | -0.68 | 1 | +0.00 |
| @tradealgo_ | C | -1.28 | 1 | +0.30 |
| @FluxCharts | C | -3.34 | 1 | +0.70 |
| @KeithTradeSmith | C | +0.25 | 1 | +0.40 |
Recent signals30of 52 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-27 | @jimmyhuli | +0.55 | Discloses multiple existing long positions across biotech and AI-related names. | -3.9% | tweet ↗ |
| 2026-08-25 | @eugeniodeveze | +0.60 | KURA completed a breakout and began filling the gap. | -6.8% | tweet ↗ |
| 2026-08-25 | @Brad_E_Schulz | +0.10 | Quantifies strong sector breadth and lists leading stocks. | -6.8% | tweet ↗ |
| 2026-08-25 | @Brad_E_Schulz | +0.15 | Screens stocks rising at least 4% on elevated relative volume. | -6.8% | tweet ↗ |
| 2026-08-25 | @KeithTradeSmith | +0.40 | Uses broad new-high participation across sectors to argue the market is healthy; capped at six tickers. | -6.8% | tweet ↗ |
| 2026-08-25 | @sunxliao | +0.45 | Highlights KURA's 10% gain and expects substantially more biotech trades in coming weeks. | -6.8% | tweet ↗ |
| 2026-08-25 | @FluxCharts | +0.70 | Describes a range breakout with explicit target and invalidation levels. | -6.8% | tweet ↗ |
| 2026-08-25 | @Brad_E_Schulz | +0.10 | Reports quantified intraday performance across stock categories. | -6.8% | tweet ↗ |
| 2026-08-25 | @Brad_E_Schulz | +0.15 | Lists stocks up at least 4% on 1.5x or greater average volume. | -6.8% | tweet ↗ |
| 2026-08-25 | @OptionsFlowBoss | +0.45 | Lists unusual bullish pharma options-volume multiples; ticker output capped at six. | -6.8% | tweet ↗ |
| 2026-08-25 | @Maximus_Holla | +0.45 | Calls KURA's daily chart a beauty, expressing a positive technical lean. | -6.8% | tweet ↗ |
| 2026-08-25 | @Maximus_Holla | +0.25 | Appears to disclose a small KURA position, with details dependent on attached media. | -6.8% | tweet ↗ |
| 2026-08-25 | @CEOStockWatcher | +0.30 | Kura Oncology's CEO bought another $1.24M alongside two other insiders. | -6.8% | tweet ↗ |
| 2026-08-25 | @tradealgo_ | +0.30 | Reports KURA CEO Troy Wilson bought 100,000 shares at a $12.39 average. | -6.8% | tweet ↗ |
| 2026-08-25 | @Maximus_Holla | +0.60 | Forecasts KURA reaching 18–20 or higher over time. | -6.8% | tweet ↗ |
| 2026-08-25 | @judahrhodie | +0.30 | KURA's president and CEO reportedly bought $1.2 million of shares on August 24, 2026. | -6.8% | tweet ↗ |
| 2026-08-25 | @OpenOutcrier | +0.30 | Kura Oncology CEO Troy Wilson bought $1.24M of KURA shares. | -6.8% | tweet ↗ |
| 2026-08-25 | @TENETTRADEGROUP | +0.00 | Pre-market movers list identifies active tickers without directional commentary. | -6.8% | tweet ↗ |
| 2026-08-25 | @Briefingcom | +0.30 | Kura Oncology's president and CEO bought 100,000 shares for about $1.2 million. | -6.8% | tweet ↗ |
| 2026-08-25 | @jimmyhuli | +0.25 | Calls the recent biotech accumulation successful while questioning the premarket surge. | -6.8% | tweet ↗ |
| 2026-08-25 | @Briefingcom | +0.30 | Lists premarket gap percentages; capped at six tickers in stated order. | -6.8% | tweet ↗ |
| 2026-08-25 | @semodough | +0.35 | Highlights Kura's $1.1B market cap and $500M cash balance as a favorable valuation setup. | -6.8% | tweet ↗ |
| 2026-08-24 | @MinervaCap | +0.00 | Daily watchlist names top trades for tomorrow without concrete entry intent or visible levels. | +2.1% | tweet ↗ |
| 2026-08-24 | @jimmyhuli | +0.60 | Describes rotation from AI hardware into crypto and biotech with several stock-specific views. | +2.1% | tweet ↗ |
| 2026-08-24 | @sunxliao | +0.70 | Says KURA resistance flipped to support amid a strengthening biotech theme. | +2.1% | tweet ↗ |
| 2026-08-24 | @semodough | +0.30 | Reports Kura's CEO buying 100,000 shares at $12.39, worth about $1 million. | +2.1% | tweet ↗ |
| 2026-08-24 | @Maximus_Holla | +0.30 | Author reports another insider transaction near KURA's 52-week high. | +2.1% | tweet ↗ |
| 2026-08-24 | @LogicalThesis | +0.50 | Reports another $1.2M CEO purchase and adds a bullish personal target and position disclosure. | +2.1% | tweet ↗ |
| 2026-08-24 | @zohmbastic | +0.30 | Thin text indicates another KURA CEO transaction, apparently an insider purchase. | +2.1% | tweet ↗ |
| 2026-08-24 | @eugeniodeveze | +0.00 | Notes KURA is testing resistance without stating the outcome. | +2.1% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.